Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001868279-22-000002
Filing Date
2022-12-29
Accepted
2022-12-29 11:39:51
Documents
1
Effectiveness Date
2022-12-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9955
  Complete submission text file 0001868279-22-000002.txt   11031
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Filer) CIK: 0001868279 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-469072 | Film No.: 221497473